AlloVir logo
AlloVir ALVR

Annual report 2025
added 03-17-2026

report update icon

AlloVir Total Current Liabilities 2011-2026 | ALVR

Annual Total Current Liabilities AlloVir

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
9.71 M 24.7 M 28.4 M 24.3 M 37.9 M 12.3 M - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
37.9 M 9.71 M 22.9 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Cerus Corporation Cerus Corporation
CERS
101 M $ 2.59 -4.78 % $ 494 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
47.5 M - - $ 269 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
16.4 M $ 1.61 -2.42 % $ 108 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Atreca Atreca
BCEL
16.3 M - -11.76 % $ 5.79 M usaUSA
Berkeley Lights Berkeley Lights
BLI
45.5 M - -7.31 % $ 87 M usaUSA
Cue Biopharma Cue Biopharma
CUE
13.5 M $ 34.94 17.05 % $ 3.31 B usaUSA
Calithera Biosciences Calithera Biosciences
CALA
14 M - -10.95 % $ 876 K usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
36.8 M - - $ 3.45 B usaUSA
ChemoCentryx ChemoCentryx
CCXI
63 M - - $ 3.74 B usaUSA
Editas Medicine Editas Medicine
EDIT
46.2 M $ 3.04 1.33 % $ 270 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Caladrius Biosciences Caladrius Biosciences
CLBS
5.61 M - -16.75 % $ 25.8 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
9.38 M - - $ 231 M usaUSA
Exelixis Exelixis
EXEL
406 M $ 44.42 0.57 % $ 12.1 B usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
395 M $ 22.35 0.72 % $ 3.7 B usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
11 M - -2.5 % $ 5.88 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
100 M - - $ 2.18 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
78.6 M - - $ 2.02 B usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
36.6 M - - $ 28.6 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.73 M $ 3.5 5.42 % $ 5.76 M israelIsrael
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
53.3 M - -9.21 % $ 2.55 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
23.1 M - -5.68 % $ 8.28 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
3.98 M $ 8.87 1.66 % $ 80.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
71.2 M - - $ 8.42 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada